Massive Recall of Epinephrine Auto Injector Alarms Users
On October 28th, 2015 a recall was announced for all Auvi-Q (epinephrine injection, USP) because of the possibility of delivering an inaccurate dosage of the medication. This recall includes all Auvi-Q devices, both 0.15mg and 0.3mg strength, on the market today, and affects consumers, retailers, and hospitals. This device, used to treat life-threatening allergies, has no room for error. However, 26 suspected malfunctions had been reported by October 26, although none resulted in fatalities.
Panic Amongst Users and Parents Of Allergic Children
This announcement spread virally via Facebook and other media sources, sending users and parents of users into a panic. For years, Epi-Pen has been the only product available for those who needed to carry a life-saving dose of epinephrine. Auvi-Q has been around for two years but was gaining in popularity. Because an allergic individual should never be without an epinephrine autoinjector, the recall prompted a rush on demand for Epi-Pens.
The looming Halloween holiday, combined with the recall, was particularly alarming to parents of allergic children, as such out-of-the-ordinary, food-centered celebrations are when children are most at risk for contact with allergens. Parents were also scrambling Wednesday evening and Thursday morning to obtain new Epi-Pens to replace Auvi-Q devices that were left with school nurses throughout the country.
Why Auvi-Q Has Become So Popular
Approved by the FDA in August 2012, Auvi-Q the talking auto-injector was the first product of its kind to talk users through the steps to use it. More streamlined than Epi-Pen, it was also easier and more comfortable to carry, making it a top choice amongst young people. A recent article in the Seattle Times revealed that there are injuries associated with use of the traditional Epi-Pen, because of its large needle and long 10 second delivery time. This led to online discussion of how much quicker the delivery system is with Auvi-Q, and how the needle is significantly smaller and more comfortable. Such positive press for Auvi-Q has led to many epinephrine users making the switch.
Today, those users are scrambling to find a reliable substitute, as Auvi-Q no longer has any of its products that have not been recalled. In addition to the U.S. recall, a recall was also announced for the product in Canada.
If you have an Auvi-Q device, immediately call your healthcare provider and get a prescription for a new epinephrine auto0injector.
Details of this recall can be found here: https://www.auvi-q.com/